DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2CYCLOSPORINE
02 1LOPERAMIDE HYDROCHLORIDE
01 121855
02 165044
03 165054
01 3No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : CYCLOSPORINE
Dosage Form : CAPSULE; ORAL
Application Number : 65044
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : CYCLOSPORINE
Dosage Form : SOLUTION; ORAL
Application Number : 65054
Country : US
Patented : No
Drug : LOPERAMIDE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 21855
Country : US
Patented : No
